MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fimmu.2026.1829916

Медицинская библиотека · Frontiers in immunology · 2026

Evaluation of a strain Long human respiratory syncytial virus with M2-2 gene deletion in intranasally vaccinated BALB/c mice.

Shu Ri-Gan, Jun Jie, Zheng Yun-Xuan, Yue Dan-Ning, Hu Hao, Xu Hua-Wei, Zhao Xiao-Lei, Wang Hong-Ru, Liu Xi-Man, Zhang Yi-Peng, Wang He, Yu Jie-Mei, Zheng Yan-Peng, Peng Xiang-Lei, Fu Yuan-Hui, He Jin-Sheng

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Human respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract illness (LRTI) worldwide, particularly in infants, the elderly and immunocompromised individuals. Despite this substantial disease burden, no licensed pediatric vaccines are currently available for infants aged ≥ 6 months, highlighting an urgent need for effective immunization strategies.

METHODS

Live-attenuated vaccines (LAVs) were developed and characterized based on RSV subgroup A strain Long (wtRSV) by deleting the M2-2 gene alone or by further introducing silent mutations into the small hydrophobic (SH) gene alongside a 112-nucleotide deletion within its downstream untranslated region. Subsequently, the in vitro and in vivo characteristics of these constructed recombinant RSV strains were evaluated.

RESULTS

In HEp-2 and Vero cells, the recombinant strains RLΔM2-2 and RLΔM2-2112 displayed reduced replication capability compared with the parental wtRSV. In BALB/c mice, RLΔM2-2-infected groups demonstrated significantly lower lung viral loads and less pronounced body weight loss than those infected with RLΔM2-2112. Following intranasal immunization, RLΔM2-2 robustly induced systemic and pulmonary humoral and cellular immune responses including preF-specific antibodies, neutralizing antibody responses, and RSV-specific CD8+ T-cell responses characterized by a Th1-biased immune profile. Furthermore, the vaccine conferred protection against subsequent RSV challenge with no signs of enhanced respiratory disease (ERD).

CONCLUSION

These results support the application of M2-2 deletion strategy to the parental RSV strain Long backbone, providing a solid foundation for further evaluation and development of RSV LAVs.

Для цитирования: Shu Ri-Gan, Jun Jie, Zheng Yun-Xuan, Yue Dan-Ning, Hu Hao, Xu Hua-Wei, Zhao Xiao-Lei, Wang Hong-Ru, Liu Xi-Man, Zhang Yi-Peng, Wang He, Yu Jie-Mei, Zheng Yan-Peng, Peng Xiang-Lei, Fu Yuan-Hui, He Jin-Sheng. Evaluation of a strain Long human respiratory syncytial virus with M2-2 gene deletion in intranasally vaccinated BALB/c mice.. Frontiers in immunology. 2026. DOI: 10.3389/fimmu.2026.1829916.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.